Chao Huang

Years Active: 2017-2024
Publications (10 Years): 6

This page only lists publications with an associated author ORCID identifier.

Publications

Hongwei Zhao, Panpan Zhao, Chao Huang
Targeted inhibition of SUMOylation: treatment of tumors. Human cell 37 (5) (2024)
Hongwei Zhao, Panpan Zhao, Chao Huang
Targeted inhibition of SUMOylation: treatment of tumors. Human cell (2024)
Wei Wang, Xiangjun Wang, Feng Yao, Chao Huang
Lysyl Oxidase Family Proteins: Prospective Therapeutic Targets in Cancer. International journal of molecular sciences 23 (20) (2022)
Xiang-Rong Li, Xiaju Cheng, Jia Sun, Yan S Xu, Nannan Chen, Yimei Hao, Chao Huang, Y Eugene Chin
Acetylation-dependent glutamate receptor GluR signalosome formation for STAT3 activation in both transcriptional and metabolism regulation. Cell death discovery 7 (1) (2021)
Yang Wang, Jing Tian, Chao Huang, Jiao Ma, Gaolei Hu, Yalan Chen, Tianshi Wang, Rong Cai, Yong Zuo, Hongsheng Tan, Qiuju Fan, Baijun Dong, Wei Xue, Jing Yi, Guoqiang Chen, Jun Tu, Jinke Cheng
P53 suppresses SENP3 phosphorylation to mediate G2 checkpoint. Cell discovery 6 (2020)
Jing Shen, Xueping Xiang, Lihan Chen, Haiyi Wang, Li Wu, Yanyun Sun, Li Ma, Xiuting Gu, Hong Liu, Lishun Wang, Ying-Nian Yu, Jimin Shao, Chao Huang, Y Eugene Chin
JMJD5 cleaves monomethylated histone H3 N-tail under DNA damaging stress. EMBO reports 18 (12) (2017)

Chao Huang.css-eqlu8i{font-size:small;padding-left:4px;}